Carvedilol Tablet, Film Coated
Product Images NDC 70518-0356

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 70518-0356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Carvedilol 12.5mg 70518 0356 01)

Carvedilol 12.5 mg film-coated tablet label showing a quantity of 180 tablets. The label includes RX only designation, NDC 70518-0356-01, manufacturer Zydus Pharm, and repackager RemedyRepack Inc. Directions refer to the package insert. Storage conditions and a barcode are also present.*

FDA Label Image

Mm3 (Carvedilol 12.5mg 70518 0356 02)

Carvedilol 12.5 mg film-coated tablets packaging label shows quantity of 60 tablets. Label includes NDC 70518-0356-02, manufacturer Zydus Pharm, and repackager RemedyRepack Inc. Directions advise to see package insert. Storage instructions specify 20-25°C with permitted excursions. The label features a barcode and a QR code.*

FDA Label Image

Mm4 (Carvedilol 12.5mg 70518 0356 03)

Carvedilol 12.5 mg film-coated tablets, quantity 90, repackaged by RemedyRepack Inc. The label includes barcode, NDC number 70518-0356-03, manufacturer listed as Zydus Pharm, Pennington, NJ, and storage instructions at 20-25°C with permitted excursions. Directions advise to see package insert.*

FDA Label Image

Remedy_label (Remedy Label)

Carvedilol 12.5 mg film-coated tablet label showing a quantity of 30 tablets. The label includes the NDC number 70518-0356, manufacturer info as Zydus Pharm, Pennington, NJ, and the repackager as RemedyRepack Inc., Indiana, PA. It contains storage instructions and a QR code along with barcode and dosage form details.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure diagram of Carvedilol, showing its molecular components including methoxyphenyl and indole groups connected by a hydroxypropanolamine chain.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line chart showing mortality percentage over time in months for Carvedilol versus placebo groups. The graph depicts lower mortality rates with Carvedilol compared to placebo, with a statistically significant difference (P=0.0014). The x-axis represents months, and the y-axis represents percent mortality, up to 30%. *

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot depicting hazard ratios and confidence intervals for Carvedilol across various patient subgroups including gender, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure levels, and spironolactone use, with a reference line at hazard ratio 1.0.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph comparing mortality percentage over 24 months for two groups labeled Carvedilol and Placebo. The x-axis represents months, and the y-axis shows percentage mortality, illustrating lower mortality in the Carvedilol group compared to Placebo with a p-value of 0.03.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

Forest plots showing hazard ratios for various subgroups in two separate analyses. The subgroups include age, gender, timing post-myocardial infarction, prior or no prior use of Ivabradine, Killip class, thrombolytic therapy status, PTCA status, CHF history, diuretic use, angina presence, hypertension, diabetes, heart rate, and systolic blood pressure. Each subplot compares hazard ratios with confidence intervals around the value of 1.0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.